ANT-INTERNATIONAL
27.6.2024 07:12:29 CEST | Business Wire | Press release
On 2024 International MSME Day, Ant International, a digital payment and financial services leader, shares that it supports almost 100 million Micro, Small, and Medium-sized Enterprises (MSMEs) worldwide across its businesses and partner programs; and reinforces its commitments towards MSME digitalization and inclusion through the expansion of its services, new programs for skills development with industry partners, and a new global campaign.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20240626356788/en/
(Photo: Business Wire)
“MSMEs are the lifeblood of our economies, driving innovation, employment, and inclusive development,” said Douglas Feagin, President of Ant International. “Their resilience and entrepreneurial spirit deserve to be celebrated and nurtured. At Ant International, we firmly believe in the power of small and that small businesses can make a big impact. Fintech innovations today unlock new possibilities for small businesses to dream boldly and compete globally. Together with our partners, we want to ensure that every business and every person will have access to the knowledge, network, and digital tools to help them achieve their goals.”
Empowering growth for MSMEs through digitalization
Across its businesses, Ant International offers solutions that enable MSMEs to digitalize, opening new growth opportunities.
Alipay+, the cross-border mobile payments and marketing solutions operated by Ant International, announced an expansion of its global acceptance. As of June 2024, Alipay+ is accepted by over 90 million merchants in over 66 markets, connecting businesses to users of 30 international payment partners. With travel picking up and tourism a key driver of many local economies, this enables many small businesses to connect with global mobile-first consumers in a simple, cost-efficient manner.
A key development in driving digitalization at scale is through Alipay+’s integration with national QRs. Alipay+ is currently integrated with the national QRs of Singapore, Malaysia and South Korea, which counts MSMEs as majority of its merchants. In Singapore, Alipay+ transactions at hawker stalls have increased 52% in H1 2024, compared to H2 2023. In Malaysia and South Korea, Alipay+ transactions increased 44% and 54% respectively via PayNet and ZeroPay, in Q2 vs Q1 2024. Alipay+ also has partnerships with national QRs in Cambodia, Nepal and Sri Lanka.
As a leading provider of digital payment solutions, Antom supports merchants of all sizes, including MSMEs, across over 40 countries and regions. Through a single integration, Antom connects them to more than 250 payment methods in over 150 markets. Its D-store solution enables MSME merchants to digitalize their operations and set up an online store in just 10 minutes with zero upfront cost. Over 5000 outlets have already onboarded this solution, with average monthly transactions growing by 27% in Q2 vs Q1 2024.
In supporting MSMEs to do business globally, WorldFirst empowers more than 1 million SMEs with international payments to 200+ markets in over 100 currencies. To enable more SMEs to do cross-border trade, WorldFirst will expand to more markets in Southeast Asia and Europe this year. ANEXT Bank, a digital wholesale bank incorporated in Singapore, recently celebrated its second anniversary, with two times year-on-year increase in its customer base, of which 69% are micro businesses. To further support regional MSMEs, ANEXT Bank has introduced its second batch of SME Friends of ANEXT with forward-thinking small and growing businesses to co-create the “digital bank of tomorrow”.
Ant International has also recently unveiled bettr, a new global digital lending service to provide micro lending to MSMEs through embedded finance partnerships, further accelerating financial inclusion.
Harnessing industry partnerships to drive MSME development
Ant International believes in open industry collaboration to jointly support knowledge and skills development for MSMEs.
In Indonesia, Ant International and DANA will launch the second edition of SisBerdaya, an initiative that provides female micro entrepreneurs training, mentoring, and educational programs in business management and digital skills. Started in 2023, the first edition drew more than 2700 applicants, with 180 participants undergoing a one-month training, and grants awarded to 30 entrepreneurs.
In collaboration with the International Finance Corporation, 10x1000 Tech for Inclusion is an open learning platform to help future digital leaders develop more skills to drive greater impact within their communities. As of 2023, with the support of 40+ global strategic partners, more than 6,000 individual talents from 100+ countries and regions completed the 10x1000 learning programs, of which 90% are from developing markets and 60% work in MSMEs.
Earlier this year, Ant International launched Programme Sirius, with the support of 13 Asia Pacific fintech leaders to empower MSMEs in their transition towards sustainability, in line with the United Nationals Sustainable Development Goals.
Global campaign to ‘Embrace the power of small’
In celebration of International MSME Day, Ant International launches its “Embrace the power of small” campaign featuring three business owners and their journeys of digitalization. The business owners are:
Cholthicha Joyyangsuk (Numwan), Thailand – a micro entrepreneur in Bangkok selling Thai desserts on her tuktuk. With Alipay+, she can now easily accept mobile payments from tourists, sharing a slice of culture, while giving her access to a wider pool of customers.
Lem Cheong, The Hainan Story, Singapore – inspired by his grandma’s rich heritage and flavourful recipes, Mr Cheong aims to evolves traditional dishes, just as he evolves his business with digital tools like Antom’s D-store solution to simplify his store operations.
Lewis Ames, Wrimes Cosmetics, UK – starting with neon face paint and pivoting to pet care during the pandemic, Mr Ames uses WorldFirst to pay his suppliers and collect payments from marketplaces easily, so he can grow his business from Stevenage to the world.
These stories will be featured on out-of-home billboards, starting in Europe, in time for the UEFA EURO 2024, of which Ant International is the Official Payment Partner, and rolled out to other global markets, and also on TV and social media.
About Ant International
Headquartered in Singapore, Ant International powers the future of global commerce with digital innovation for everyone and every business to thrive. In close collaboration with partners, we support merchants of all sizes worldwide to realize their growth aspirations through a comprehensive range of tech-driven digital payment and financial services solutions.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240626356788/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
Barilla Opens Global Call for Startups Through Good Food Makers 202625.5.2026 11:47:00 CEST | Press release
The program has involved over 1,100 startups across 50+ countries, delivering 26 pilot projects. Barilla Group has opened applications for the 2026 edition of Good Food Makers, its global open innovation program designed to co-develop and test new innovative solutions with startups and innovators inside real industrial environments. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260521973445/en/ Since its launch in 2019, the program has involved more than 1,100 startups from over 50 countries, leading to 26 pilot projects, with over 20 projects currently active thanks to the solutions developed by the program’s alumni. This highlights the program’s role as a concrete platform for industrial scalable innovation. The 2026 edition comes at a pivotal moment for the company, following the launch of BITE (Barilla Innovation & Technology Experience), the new innovation center dedicated to developing the next generation of food prod
JEOL: Sales Launch of the Laser SEM System “LazEdge”25.5.2026 10:16:00 CEST | Press release
JEOL Ltd. (President & CEO: Izumi Oi) has developed the “LazEdge”, an SEM system equipped with a laser processing system, and begins sales on May 25, 2026. Cross-section preparation instruments such as the focused ion beam system (FIB system), are widely used in science and technology fields across research institutes, universities, and industries. In recent years, demand is increasing for a system that can process large-areas at a high speed, while achieving high-quality of the processed surface. “LazEdge” is an instrument integrating JEOL’s SEM with the laser technology proprietary of Hamamatsu Photonics K.K., and enables laser processing inside the specimen chamber of the electron microscope. This system enables high-quality cross-section specimens produced through high-speed, large-area processing to be transferred seamlessly to subsequent analyses, such as SEM observation, elemental analysis, and crystal orientation analysis, without exposure to the external environment. As a resu
TFG-001, A Novel 3D Neural Microtissue Cell Therapy, Demonstrates Superior Functionality and Reinnervation for Parkinson’s Disease25.5.2026 08:00:00 CEST | Press release
TreeFrog Therapeutics, a regenerative medicine biotech company developing next-generation cell therapies, today announced that it will present new preclinical data on TFG-001 at the 7th World Parkinson’s Conference. TFG-001, a 3D neural microtissue cell therapy, demonstrated rapid dopamine release and extensive graft-derived reinnervation across multiple advanced translational Parkinson’s disease models—supporting its potential as a best-in-class candidate. The critical need for reinnervation in Parkinson's disease In Parkinson's disease, an estimated 60–80% of dopaminergic neurons are already lost before motor symptoms even appear. The nigrostriatal pathway degenerates, destroying the essential wiring that connects dopamine-producing neurons to movement control. While chemical dopamine replacements (like levodopa) can manage symptoms, they cannot restore the spatial precision, feedback loops, or dynamic regulation of a healthy brain network. To achieve true functional restoration, it
Galderma Receives U.S. FDA Approval for Differin® Epiduo® Acne Gel Prescription-to-OTC Switch22.5.2026 18:25:00 CEST | Press release
A unique Prescription-to-OTC switch in acne care, this approval expands access to a dermatologist-trusted, prescription-strength treatment for millions of acne sufferers ages 12 years and older Backed by more than 15 years of real-world dermatologist use and a robust clinical research program, this milestone demonstrates the depth of science behind the Differin® and Epiduo® heritage Adapalene plus benzoyl peroxide (0.1/2.5%) was the first FDA-approved, stable, fixed- dose prescription acne treatment to combine of benzoyl peroxide with a retinoid, and is now available over-the-counter The formulation is engineered to target multiple causes of acne more effectively than either of its individual active ingredients alone Galderma (SIX: GALD), the pure-play dermatology category leader, today announced that the United States (U.S.) Food and Drug Administration (FDA) has approved Differin® Epiduo® Acne Gel (Adapalene 0.1% and Benzoyl Peroxide 2.5% Acne Treatment) for over-the-counter (OTC) us
Avanzanite Bioscience’s Partner Agios Announces PYRUKYND® (mitapivat) Approval in the European Union for Adults with Thalassaemia22.5.2026 16:18:00 CEST | Press release
Avanzanite will commercialise and distribute PYRUKYND in Europe under its exclusive agreement with Agios Avanzanite is committed to collaborating with local authorities in the EU to enable access to PYRUKYND for adult patients with thalassaemia Avanzanite Bioscience B.V., a rapidly growing commercial-stage European specialty pharmaceutical company focused on rare diseases, today reported that its partner, Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company headquartered in Cambridge, Massachusetts focused on delivering innovative medicines for patients with rare diseases, announced that the European Commission has granted marketing authorisation for PYRUKYND® (mitapivat), an oral pyruvate kinase (PK) activator, in adults for the treatment of anaemia associated with transfusion-dependent and non-transfusion-dependent alpha- or beta-thalassaemia, with an orphan medicinal product designation. This press release features multimedia. View the full releas
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom